Risk of acute kidney injury associated with anti-pseudomonal and anti-MRSA antibiotic strategies in critically ill patients.
Jean Maxime CôtéMichaël DesjardinsJean-François CailhierPatrick T MurrayWilliam Beaubien-SoulignyPublished in: PloS one (2022)
These results suggest that the risk of AKI in ICU patients requiring antibiotherapy may be partially mitigated by the choice of antibiotics administered. Further clinical trials are required to confirm these findings.
Keyphrases
- acute kidney injury
- clinical trial
- end stage renal disease
- cardiac surgery
- chronic kidney disease
- ejection fraction
- newly diagnosed
- intensive care unit
- staphylococcus aureus
- prognostic factors
- methicillin resistant staphylococcus aureus
- randomized controlled trial
- decision making
- patient reported outcomes
- phase ii
- phase iii